Published On:July 11, 2017, 10:05 am
Urolithiasis is the process of forming stony concretions in the bladder, kidney or urinary tract. These stony concretions are also referred as kidney stones. A small stone may pass through the urine stream and leaves the body without causing symptoms. But if a stone grows to more than 5 mm, it can cause blockage of the ureter leading to acute pain in the abdomen or lower back. A kidney stone may also lead to painful urination, blood traces in the urine, or vomiting. Approximately, 50% of people will have the recurrence of kidney stone within a decade.
The development of the stones is related to decreased urine amount or increased emission of stone-forming elements such as phosphate, oxalate, xanthine, urate, cysteine, and calcium. The stones form in the pelvis (the urine collecting area) of the kidney and may vary in size from tiny to large stones (staghorn stones). The staghorn stones are the size of almost the renal pelvis itself. There are various methods for the Urolithiasis management. Improving the quality of life is the natural method. That includes sufficient water intake, following prescribed diet, regular exercise etc. Other methods comprise kidney stone management devices and drug treatment.
In 2015, the Global Urolithiasis Management Device Market was valued approximately USD 1.27 billion. It is expected to reach USD 1.92 billion by the end of 2022. The compound annual growth rate is expected to 4.5% during the forecast period of 2017 to 2022. The global demand for urolithiasis management devices has seen a robust rise in the earlier period due to the escalating occurrence of kidney stones. Major factors driving the urolithiasis management device market are increasing awareness, growing geriatric population as well as processions in technology due to several external factors such as increasing investment, the debut of new market players, and government support.
The significant rise in the number of patients opting for urolithiasis surgeries instead of prolonged medications and advancements in treatment alternatives that have reduced the treatment period required for executing the procedures, these factors are fueling the global market growth. The innovations of the ground-breaking urolithiasis management devices like flexible urethroscopes and laser lithotripters have also helped the healthy growth of the global urolithiasis management device market. Varieties of alternative methods are available for the management of urolithiasis, is the only factor that may reduce the growth pace.
The key market players for the global urolithiasis management device market are Boston Scientific Corporation, C. R. Bard, Inc., Allengers Medical Systems Ltd, Guangzhou Potent Optotronic Technology Co., Ltd., Karl Storz GmbH & Co. KG, DirexGroup, Cook Medical, Olympus Corporation, Dornier MedTech GmbH, HealthTronics, Inc., ConMed Corporation, Lumenis, Siemens Healthcare and Richard Wolf. On the basis of product, the market industry is classified into; Intracorporeal Lithotripsy, Extracorporeal Shock Wave Lithotripsy, Percutaneous Nephrolithotomy and Other Treatments. By application, the market industry is split into; Hospitals, Clinics and Other. Geographically, the market is segmented into regions which are Europe, Asia-Pacific, Southeast Asia, North America and rest of the world.
Request For Sample Of Urolithiasis Management Device Market Research Report @ https://www.qyresearchgroups.com/request-sample/425046
We will be happy to help you find what you need. Please write to us: